Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 13;25(4):829.
doi: 10.3390/molecules25040829.

Measuring Sulforaphane and Its Metabolites in Human Plasma: A High Throughput Method

Affiliations

Measuring Sulforaphane and Its Metabolites in Human Plasma: A High Throughput Method

Annie Langston-Cox et al. Molecules. .

Abstract

(1) Background: There is increasing understanding of the potential health benefits of cruciferous vegetables. In particular sulforaphane (SFN), found in broccoli, and its metabolites sulforaphane-glutathione (SFN-GSH), sulforaphane-cysteine (SFN-Cys), sulforaphane cysteine-glycine (SFN-CG) and sulforaphane-N-acetyl-cysteine (SFN-NAC) have potent antioxidant effects that may offer therapeutic value. Clinical investigation of sulforaphane as a therapeutic antioxidant requires a sensitive and high throughput process for quantification of sulforaphane and metabolites; (2) Methods: We collected plasma samples from healthy human volunteers before and for eight hours after consumption of a commercial broccoli extract supplement rich in sulforaphane. A rapid and sensitive method for quantification of sulforaphane and its metabolites in human plasma using Liquid Chromatography-Mass Spectrometry (LC-MS) has been developed; (3) Results: The LC-MS analytical method was validated at concentrations ranging between 3.9 nM and 1000 nM for SFN-GSH, SFN-CG, SFN-Cys and SFN-NAC and between 7.8 nM and 1000 nM in human plasma for SFN. The method displayed good accuracy (1.85%-14.8% bias) and reproducibility (below 9.53 %RSD) including low concentrations 3.9 nM and 7.8 nM. Four SFN metabolites quantitation was achieved using external standard calibration and in SFN quantitation, SFN-d8 internal standardization was used. The reported method can accurately quantify sulforaphane and its metabolites at low concentrations in plasma; (4) Conclusions: We have established a time- and cost-efficient method of measuring sulforaphane and its metabolites in human plasma suitable for high throughput application to clinical trials.

Keywords: Liquid Chromatography–Mass Spectrometry; pharmacokinetic; sulforaphane.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Molecular structures of sulforaphane and its metabolites: Sulforaphane (SFN) sulforaphane-glutathione (SFN-GSH), sulforaphane-cysteine (SFN-Cys), sulforaphane cysteine-glycine (SFN-CG) and sulforaphane-N-acetyl-cysteine (SFN-NAC).
Figure 2
Figure 2
Extracted ion chromatograms of 7.8 nM spiked extracted plasma. SFN and SFN-CG peaks were produced due to in-source fragmentation are marked with arrows. Transitions from the top to the bottom: SFN-Cys, SFN-d8, SFN-NAC-d8, SFN-CG, SFN-GSH, SFN, and SFN-NAC. Peaks produced by in source ionization marked with “ * ”.
Figure 3
Figure 3
Pharmacokinetic profiles of SFN and metabolites in plasma taken from participant one (dotted line) and participant two (solid line) over 8 h. Metabolites are: (a) SFN, (b) SFN-Cys, (c) SFN-GSH, (d) SFN-CG, (e) SFN-NAC and (f) Total all metabolites (combined value of all metabolites). Y-axis represents measured concentration in ng/ML.

References

    1. Wang X., Ouyang Y., Liu J., Zhu M., Zhao G., Bao W., Hu F.B. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 2014;349:g4490. - PMC - PubMed
    1. O’Mealey G.B., Berry W.L., Plafker S.M. Sulforaphane is a Nrf2-independent inhibitor of mitochondrial fission. Redox. Biol. 2017;11:103–110. doi: 10.1016/j.redox.2016.11.007. - DOI - PMC - PubMed
    1. Riboli E., Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am. J. Clin. Nutr. 2003;78:559–569. doi: 10.1093/ajcn/78.3.559S. - DOI - PubMed
    1. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 2006;5:493–506. doi: 10.1038/nrd2060. - DOI - PubMed
    1. Bhat K.P.L., Kosmeder J.W., Pezzuto J.M. Biological Effects of Resveratrol. Antioxid. Redox Signal. 2001;3:1041–1064. doi: 10.1089/152308601317203567. - DOI - PubMed